TABLE 1.
Factors involved in age‐related differences of SARS‐CoV‐2 pathogenesis | Adults | Children | References |
---|---|---|---|
Expression of ACE2 receptor and TMPRSS2 | ↑ | ↓ | 96, 98, 136 |
Comorbidities and medications | ↑ | ↓ | 99, 100, 101, 102 |
Innate immune responses | ↓ | ↑ | 103 |
Adaptive immune responses | ↑ | ↓ | 72, 109 |
Pre‐existing antibodies to other HCoVs | ↑ | ↓ | 104, 109 |
Trained immune responses | ↓ | ↑ | 125, 126 |
ADE and macrophage hyperactivation | ↑ | ↓ | 106, 117, 119 |
Cytokine storm | usually ↑ | usually ↓(except for MIS‐C) | 80, 121, 122 |
Vitamin D and other micronutrients | ↓ | ↑ | 127, 130 |
SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; ACE2, angiotensin‐converting enzyme 2; TMPRSS2, transmembrane protease serine 2; HCoVs, human coronaviruses; ADE, antibody‐dependent enhancement; MIS‐C, multisystem inflammatory syndrome in children.